跳至主要内容
临床试验/JPRN-UMIN000018480
JPRN-UMIN000018480已完成2 期

Human atrial natriuretic peptide during perioperative period for completely resected non-small cell lung cancer: a multicentre, open-label, randomised controlled trial - Japan Human Atrial Natriuretic Peptide for Lung Cancer Surgery (JANP study)

ational Cerebral and Cardiovascular Center0 个研究点目标入组 332 人开始时间: 2015年7月31日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
332

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Thin-section CT fulfills the proportion of maximum diameter of the tumor itself to consolidation is less than 0.25. 2. Patient with active the other concurrent malignant diseases. 3. Women during pregnancy or breast-feeding. 4. Psychosis. 5. Systemic steroids or immunosuppressive agents medication. 6. Uncontrollable infectious disease, autoimmune disease, or the other severe comorbidities. 7. History of right ventricular infarction. 8. Severe hypotension 9. Other conditions judged ineligible by physician

研究者

发起方
ational Cerebral and Cardiovascular Center

相似试验